ask="N/A"
ask_size="N/A"
average_daily_volume="1038750"
bid="N/A"
bid_size="N/A"
book_value="-0.153"
change="+0.022"
change_from_200_day_moving_average="-0.096"
change_from_50_day_moving_average="0.031"
change_from_52_week_high="-1.418"
change_From_52_week_low="0.234"
change_in_percent="+5.500%"
close="0.422"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.654"
ebitda="-18.11M"
eps_estimate_current_year="-0.590"
eps_estimate_next_quarter="-0.090"
eps_estimate_next_year="-0.450"
ex_dividend_date="N/A"
float_shares="43543000"
high="0.440"
high_52_weeks="1.840"
last_trade_date="1/13/2017"
last_trade_price="0.422"
last_trade_size="317"
last_trade_time="4:02pm"
low="0.394"
low_52_weeks="0.188"
market_capitalization="28.58M"
moving_average_200_day="0.518"
moving_average_50_day="0.391"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.000"
open="0.429"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-18.535%"
percent_change_from_50_day_moving_average="+8.059%"
percent_change_from_52_week_high="-77.065%"
percent_change_from_52_week_low="+124.468%"
previous_close="0.400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="225.732"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="0.360"
stock_exchange="ASE"
symbol="BPMX"
volume="1008132"
weeks_range_52="0.188 - 1.840"
